Princeton Capital Management LLC Eli Lilly & CO Transaction History

Princeton Capital Management LLC

$313 Million
Q3 2024

A detailed history of Princeton Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Princeton Capital Management LLC holds 14,906 shares of LLY stock, worth $11.2 Million. This represents 4.22% of its overall portfolio holdings.

Number of Shares

14,906

Previous 13,989 6.56%

Holding current value

$11.2 Million

Previous $12.7 Million 4.26%

% of portfolio

4.22%

Previous 4.19%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$772.14 - $960.02 $708,052 - $880,338	917 Added 6.56%	14,906 $13.2 Million
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $168,169 - $210,897	232 Added 1.69%	13,989 $12.7 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $164,039 - $219,461	-277 Reduced 1.97%	13,757 $10.7 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $96,109 - $113,300	183 Added 1.32%	14,034 $8.18 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $1.53 Million - $2.11 Million	3,520 Added 34.07%	13,851 $7.44 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $19,641 - $26,262	-56 Reduced 0.54%	10,331 $4.85 Million
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $231,108 - $271,426	-744 Reduced 6.68%	10,387 $3.57 Million
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $198,396 - $231,171	-617 Reduced 5.25%	11,131 $4.07 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $530,402 - $604,449	1,789 Added 17.96%	11,748 $3.8 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.88 Million - $2.21 Million	6,743 Added 209.67%	9,959 $3.23 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $18,540 - $23,041	79 Added 2.52%	3,216 $921,000
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $5,396 - $6,696	24 Added 0.77%	3,137 $867,000
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $11,966 - $14,726	54 Added 1.77%	3,113 $719,000
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $83,053 - $107,428	460 Added 17.7%	3,059 $702,000
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $79,530 - $102,956	484 Added 22.88%	2,599 $486,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $11,551 - $13,361	-79 Reduced 3.6%	2,115 $313,000
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $72,166 - $86,851	529 Added 31.77%	2,194 $360,000
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $27,143 - $33,595	228 Added 15.87%	1,665 $261,000
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $39,560 - $48,999	370 Added 34.68%	1,437 $210,000
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $1,922 - $2,090	-18 Reduced 1.66%	1,067 $119,000
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $80,517 - $95,046	1,085 New	1,085 $84,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.

Account

Princeton Capital Management LLC Eli Lilly & CO Transaction History